Decoding disease: Scott Patterson's perspectives on the power of biomarkers in drug development
Scott Patterson (Gilead Sciences Inc., CA, USA) speaks to Ashling Cannon, Journal Development Editor at BioTechniques, about his career. Patterson is a biochemist and proteomics and biomarker/translational expert with over 30 years of industry experience following 13 years in an academic setting. Pa...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2024-01-01
|
| coleção: | BioTechniques |
| Acesso em linha: | https://www.future-science.com/doi/10.2144/btn-2023-0108 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|